Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
Les Nouvelles - Licensing Executives Society International (LESI)
David Inglefield, Ph.D., is a technical advisor in the firm’s Chemical Patent Prosecution group where he focuses on preparing and prosecuting patent applications for domestic and international clients. His graduate and industrial research experience provides firsthand knowledge across a wide range of chemical and polymer technologies.
Prior to joining the firm, Dr. Inglefield earned his doctoral degree in Chemistry from Virginia Tech, where he studied intramolecular interactions in polymer nanocomposites. In addition to expertise in polymer synthesis and nanocomposites, Dr. Inglefield has an extensive life sciences background.
Following graduate school, Dr. Inglefield worked in product development research roles across diverse technologies, utilizing fundamental structure-property relationships to drive new product development. After gaining extensive experience in industrial chemical research, Dr. Inglefield has worked as a patent engineer at a firm in Texas, where he focused on drafting and prosecuting chemical and oilfield patent applications.